Gamida Cell Ltd (NASDAQ:GMDA)
-- USD
0.000 0.000%Sponsored Reports
Previous Close (in USD) | -- |
---|---|
Change | 0.000 0.000% |
52 W H/L (in USD) | 2.510/0.008 |
EBITDA (in USD) | -75.91M |
PE Ratio | -- |
Volume | -- |
Diluted Eps TTM | -0.82 |
Total Assets (in USD) | 102.186M |
---|---|
Total Liabilities (in USD) | 105.135M |
Revenue TTM (in USD) | 0.673M |
Cash (in USD) | 49.61M |
Market Cap (in USD) | 4.337 M |
Revenue Per Share TTM | 0.007 |
Gross Profit TTM (in USD) | -- |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Gamida Cell Ltd
Employees: 143
Key Executives
Sr. No. | Name | Title | Year Born |
---|---|---|---|
1. | Mr. Shai Lankry CPA, M.B.A. | Chief Financial Officer | 1976 |
2. | Ms. Michele Ilene Korfin M.B.A., R.Ph. | Chief Operating & Chief Commercial Officer | 1972 |
3. | Dr. Ronit Simantov M.D. | Chief Medical & Chief Scientific Officer | 1965 |
4. | Ms. Abigail L. Jenkins | Pres, CEO & Director | 1976 |
5. | Mr. Joshua F. Patterson | Gen. Counsel & Chief Compliance Officer | 1976 |
6. | Mr. Paul Nee | VP of Marketing | NA |
7. | Mr. Naftali Brikashvili CPA | Sr. VP Fin. & Operations | NA |
8. | Dr. Tracey Lodie Ph.D. | Scientific Advisor & Consultant | 1970 |
9. | Mr. Vladimir Melnikov | Sr. VP of Global Operations & Manufacturing | NA |
10. | Heather DiVecchia | Chief of Staff | NA |
Peers
Sector: Healthcare
Industry: Biotechnology
Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
NVO
Novo Nordisk A/S |
+0.400 0.339% | 118.59 | 41.580 | 31.153 | 2.134 | 32.989 | 2.113 | 4.700 |
NONOF
Novo Nordisk A/S |
+2.040 1.755% | 118.3 | 41.060 | 31.250 | 2.078 | 33.111 | 2.113 | 4.700 |
VRTX
Vertex Pharmaceuticals Inc |
+11.165 2.291% | 490 | 29.670 | 24.331 | 10.385 | 5.832 | 9.334 | 20.004 |
REGN
Regeneron Pharmaceuticals Inc |
-6.665 0.661% | 1010.05 | 29.070 | 20.121 | 7.570 | 3.823 | 6.950 | 19.423 |
Income Statement
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Income Before Tax | -79.375M | -89.793M | -72.704M | -34.421M | -52.861M |
Minority Interest | - | - | - | - | - |
Net Income | -154.368M | -92.419M | -76.448M | -34.351M | -52.931M |
Selling General Administrative | 19.401M | 16.977M | 12.167M | 12.091M | 11.599M |
Gross Profit | - | - | - | - | 0M |
Reconciled Depreciation | 0.44M | 0.431M | 2.397M | 2.143M | 0.269M |
Ebit | 74.993M | -87.167M | -62.3M | -48.245M | -32.871M |
Ebitda | -74.553M | -86.736M | -59.667M | -28.953M | -32.602M |
Depreciation And Amortization | -149.546M | 0.431M | 2.633M | 19.292M | 0.269M |
Operating Income | 74.993M | -87.167M | -62.3M | -48.245M | -33.644M |
Other Operating Expenses | 74.993M | 87.167M | 62.3M | 48.245M | 33.644M |
Interest Expense | 4.382M | 2.626M | 10.64M | 3.325M | 20.259M |
Tax Provision | - | - | 0M | -0.07M | 0.07M |
Interest Income | - | - | 0.236M | 1.245M | 0.877M |
Net Interest Income | -4.382M | -2.626M | -3.508M | -2.076M | -1.228M |
Income Tax Expense | 74.993M | 2.626M | 3.744M | -0.07M | 0.07M |
Total Revenue | 0M | 0M | 0M | 0M | 0M |
Total Operating Expenses | 74.993M | 87.167M | 62.3M | 48.245M | 33.644M |
Cost Of Revenue | - | - | - | - | 0M |
Total Other Income Expense Net | -154.368M | -2.626M | -10.404M | 13.824M | -17.989M |
Net Income From Continuing Ops | -79.375M | -89.793M | -72.704M | -34.351M | -52.931M |
Net Income Applicable To Common Shares | - | -89.793M | -72.704M | -34.351M | -52.931M |
Balance Sheet
(Currency in USD)Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
---|---|---|---|---|---|
Total Assets | 102.186M | 124.773M | 148.786M | 155.483M | 68.775M |
Intangible Assets | - | - | - | - | - |
Other Current Assets | 1.42M | 1.889M | 2.688M | 2.815M | 1.306M |
Total Liab | 105.135M | 132.796M | 104.849M | 56.746M | 33.792M |
Total Stockholder Equity | -2.949M | -8.023M | 43.937M | 98.737M | 34.983M |
Other Current Liab | 15.546M | 15.843M | 14.462M | 12.693M | 8.361M |
Common Stock | 0.391M | 0.211M | 0.169M | 0.166M | 0.092M |
Capital Stock | 0.391M | 0.211M | 0.169M | 0.166M | 0.092M |
Retained Earnings | -479.828M | -416.832M | -337.457M | -276.268M | -203.564M |
Good Will | - | - | - | - | - |
Other Assets | - | - | 7.756M | 0.786M | 0.641M |
Cash | 49.61M | 64.657M | 55.892M | 127.17M | 41.838M |
Cash And Equivalents | - | - | - | - | - |
Total Current Liabilities | 25.201M | 24.875M | 25.433M | 21.554M | 11.395M |
Current Deferred Revenue | - | - | - | - | - |
Net Debt | 33.333M | 39.308M | 23.827M | -119.26M | -35.867M |
Short Term Debt | 7.775M | 2.648M | 2.699M | 2.532M | 1.87M |
Short Long Term Debt | 6.505M | - | - | - | - |
Short Long Term Debt Total | 82.943M | 103.965M | 79.719M | 7.91M | 5.971M |
Other Stockholder Equity | 476.488M | 408.598M | 381.225M | 375.28M | 238.992M |
Property Plant Equipment | - | - | 42.416M | 24.712M | 11.431M |
Total Current Assets | 54.546M | 66.546M | 98.614M | 129.985M | 56.703M |
Long Term Investments | - | - | - | - | - |
Short Term Investments | 3.056M | 0M | 40.034M | 0M | 13.559M |
Net Receivables | 1.61M | - | - | 0.103M | 0.007M |
Long Term Debt | 73.041M | 96.45M | 71.417M | - | - |
Inventory | 1.906M | - | - | - | - |
Accounts Payable | 1.88M | 6.384M | 8.272M | 6.329M | 1.164M |
Accumulated Other Comprehensive Income | - | - | - | -0.441M | -0.537M |
Non Currrent Assets Other | 2.822M | 6.884M | 7.756M | 0.786M | 0.641M |
Non Current Assets Total | 47.64M | 58.227M | 50.172M | 25.498M | 12.072M |
Capital Lease Obligations | 3.397M | 7.515M | 8.302M | 7.91M | 5.971M |
Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Investments | 34.044M | -40.645M | 13.551M | 3.666M | -0.956M |
Total Cashflows From Investing Activities | - | -60.921M | 1.589M | 3.666M | -2.751M |
Total Cash From Financing Activities | 45.144M | 71.403M | 132.38M | 35.729M | 48.093M |
Net Income | -79.375M | -89.793M | -72.704M | -34.351M | -52.931M |
Change In Cash | 8.765M | -71.278M | 85.332M | 1.566M | 18.947M |
Begin Period Cash Flow | 55.892M | 127.17M | 41.838M | 40.272M | 21.325M |
End Period Cash Flow | 64.657M | 55.892M | 127.17M | 41.838M | 40.272M |
Total Cash From Operating Activities | -70.423M | -81.76M | -48.627M | -37.93M | -26.426M |
Depreciation | 0.44M | 0.431M | 2.397M | 2.143M | 0.269M |
Other Cashflows From Investing Activities | - | -5.222M | -0.158M | -0.158M | -0.15M |
Dividends Paid | - | - | - | 0.132M | - |
Change To Inventory | - | - | - | - | - |
Sale Purchase Of Stock | - | - | - | -0.238M | 47.481M |
Other Cashflows From Financing Activities | 22.846M | -60.921M | 1.049M | 0.488M | 0.614M |
Capital Expenditures | 6.354M | 15.054M | 11.804M | 3.055M | 1.645M |
Change In Working Capital | 3.638M | 4.565M | 6.911M | 1.836M | 2.833M |
Other Non Cash Items | -0.167M | -1.196M | 4.785M | 1.756M | 1.179M |
Free Cash Flow | -76.777M | -96.814M | -60.431M | -40.985M | -28.071M |
Funds
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | Fidelity VIP Growth Initial | 6 months ago | 2212268 |
2. | Fidelity Capital Appreciation | 6 months ago | 2169053 |
3. | Fidelity Advisor Equity Growth I | 6 months ago | 1892438 |
4. | Fidelity Growth Discovery | 6 months ago | 993684 |
5. | Pacific Select Large-Cap Growth I | 5 months ago | 334500 |
6. | Fidelity Advisor Series Equity Gr | 6 months ago | 266229 |
7. | Vifag 2002 SICAV | 7 months ago | 100000 |
8. | Fidelity Nasdaq Composite Index | 6 months ago | 83843 |
9. | Fidelity VIP Dynamic Cap App Initial | 6 months ago | 75514 |
10. | Dolphin 90/10 IL | 7 months ago | 65000 |
11. | Guardian Large Cap Fundamental Gr VIP | 6 months ago | 59800 |
12. | AVIP Fidelity Instl AM® Eq Gr Prtfl | 9 months ago | 33274 |
13. | 1290 VT Micro Cap K | 6 months ago | 21694 |
14. | Dolphin Flexible | 7 months ago | 14000 |
15. | Fidelity Equity Growth K6 | 6 months ago | 10294 |
16. | Dolphin Stocks IL | 7 months ago | 4000 |
17. | Dolphin75/25 IL | 7 months ago | 2700 |
18. | LUX IM Global Medtech HX | 5 months ago | 2046 |
19. | Dolphin 80/20 IL | 7 months ago | 1000 |
Institutions
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | Easterly Investment Partners. | 6 months ago | 3747630 |
2. | Meitav Dash Investments Ltd | 6 months ago | 3237537 |
3. | Nantahala Capital Management, LLC | 6 months ago | 800000 |
4. | StoneX Group Inc | 6 months ago | 793958 |
5. | Leavell T & Associates Inc | 6 months ago | 235000 |
6. | Mariner Wealth Advisors, LLC | 6 months ago | 121482 |
7. | Two Sigma Investments LLC | 6 months ago | 106081 |
8. | Stock Yards Bank & Trust Co | 6 months ago | 100000 |
9. | Virtu Financial LLC | 6 months ago | 92745 |
10. | Corsair Capital Management LLC | 6 months ago | 71260 |
11. | Phoenix Holdings Ltd | 6 months ago | 29203 |
12. | FineMark National Bank & Trust | 6 months ago | 25700 |
13. | McAdam, LLC | 6 months ago | 25629 |
14. | IEQ CAPITAL, LLC | 6 months ago | 20000 |
15. | JANE STREET GROUP, LLC | 9 months ago | 19333 |
16. | Atlantic Trust Group, LLC | 6 months ago | 14620 |
17. | Mercer Global Advisors Inc. | 6 months ago | 10000 |
18. | 1492 Capital Management, LLC | 6 months ago | 10000 |
19. | Mv Capital Management Inc | 6 months ago | 8913 |
20. | PNC Financial Services Group Inc | 9 months ago | 5500 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).